Author:
Adams J.,Unett D.,Anthony T.,Gatlin J.,Gaidarov I.
Subject
Anesthesiology and Pain Medicine,Clinical Neurology,Neurology
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone;European Journal of Medicinal Chemistry;2024-04
2. Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease;European Journal of Pharmacology;2023-10
3. Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents;Pain;2021-04-13
4. Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response;Journal of Pharmacology and Experimental Therapeutics;2021-03-03
5. Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn’s Disease;Crohn's & Colitis 360;2020-10-24